Previous 10 | Next 10 |
2024-05-06 21:30:02 ET Barclays analyst issues OVERWEIGHT recommendation for EW on May 6, 2024 08:09PM ET. The previous analyst recommendation was Overweight. EW was trading at $85.09 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...
2024-05-05 15:10:28 ET More on the markets S&P 500 1%+ Gaps Higher SPY: Don't Buy The Dip Just Yet Rate Hike Unlikely: Expect S&P 500 To Rally To New All-Time Highs Data Insight: April's jobs report was biggest disappointment in at least 2 years ...
2024-04-25 21:19:07 ET Edwards Lifesciences Corporation (EW) Q1 2024 Earnings Conference Call April 25, 2024 05:00 PM ET Company Participants Mark Wilterding - SVP & IR Bernard Zovighian - CEO Scott Ullem - CFO Daveen Chopra - Global Leader of TMTT La...
2024-04-25 16:18:53 ET More on Edwards Lifesciences Read the full article on Seeking Alpha For further details see: Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.02, revenue of $1.6B beats by $30M
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
2024-04-24 17:20:27 ET More on Edwards Lifesciences Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained) Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript BofA upgrades Edwards to buy, says double-digit growth is ...
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877...
2024-04-15 10:00:02 ET Shagun Singh from RBC Capital issued a price target of $101.00 for EW on 2024-04-15 08:08:00. The adjusted price target was set to $101.00. At the time of the announcement, EW was trading at $90.28. The overall price target consensus is at $111.78 ...
2024-04-13 09:10:00 ET Summary Wedgewood Partners is a money manager founded in 1988 with the goal of providing investors with a superior approach to managing investment portfolios. The year 2024 is off to a near-historic start with the S&P 500 Index gaining +10.5% during the ...
2024-04-11 12:17:00 ET More on Consumer Staples XLP: Expensive With Underperformance Risk XLP: Rotate Into This Lagging Sector These are the most crowded longs within consumer staples - UBS Top buy-rated stocks in consumer staples - Citi Read the fu...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that the Board of directors has determined that its in the best interest of the Company to return capital to its shareholders by way of a reduction in st...
Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve p...
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader PR Newswire Combination unlocks new future value-creation opportunities and is expected to be immed...